Tanigawara Y - Search Results

1

Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors.

Yamamoto N, Tamura T, Kamiya Y, Ono H, Kondoh H, Shirao K, Matsumura Y, Tanigawara Y, Shimada Y. Yamamoto N, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2003 Jun;33(6):302-8. doi: 10.1093/jjco/hyg051. Jpn J Clin Oncol. 2003. PMID: 12913085 Clinical Trial.

2

Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer.

Ito Y, Aiba K, Horikoshi N, Saotome T, Irie T, Sugiyama K, Nakane M, Hashimoto D, Yoshida N, Mizunuma N, Takahashi S, Tanigawara Y. Ito Y, et al. Among authors: tanigawara y. Int J Clin Oncol. 2001 Oct;6(5):242-7. doi: 10.1007/pl00012112. Int J Clin Oncol. 2001. PMID: 11723746 Clinical Trial.

3

A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy.

Takahashi Y, Sakamoto J, Takeuchi T, Mai M, Kubota T, Kitajima M, Tanigawara Y, Komatsu Y, Toge T, Saji S. Takahashi Y, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2004 Jun;34(6):342-5. doi: 10.1093/jjco/hyh067. Jpn J Clin Oncol. 2004. PMID: 15333687 Clinical Trial.

4

Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors.

Yamada Y, Tamura T, Yamamoto N, Shimoyama T, Ueda Y, Murakami H, Kusaba H, Kamiya Y, Saka H, Tanigawara Y, McGovren JP, Natsumeda Y. Yamada Y, et al. Among authors: tanigawara y. Cancer Chemother Pharmacol. 2006 Aug;58(2):173-82. doi: 10.1007/s00280-005-0149-6. Epub 2005 Nov 25. Cancer Chemother Pharmacol. 2006. PMID: 16308697 Clinical Trial.

5

Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.

Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K. Yamada Y, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2006 Apr;36(4):218-23. doi: 10.1093/jjco/hyl020. Jpn J Clin Oncol. 2006. PMID: 16684860 Clinical Trial.

6

Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.

Shirao K, Matsumura Y, Yamada Y, Muro K, Gotoh M, Boku N, Ohtsu A, Nagashima F, Sano Y, Mutoh M, Tanigawara Y. Shirao K, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2006 May;36(5):295-300. doi: 10.1093/jjco/hyl016. Epub 2006 May 15. Jpn J Clin Oncol. 2006. PMID: 16702162 Clinical Trial.

7

Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.

Boku N, Ohtsu A, Hyodo I, Shirao K, Miyata Y, Nakagawa K, Tamura T, Hatake K, Tanigawara Y. Boku N, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2007 Jun;37(6):440-5. doi: 10.1093/jjco/hym069. Jpn J Clin Oncol. 2007. PMID: 17656482 Clinical Trial.

8

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.

Shirao K, Yoshino T, Boku N, Kato K, Hamaguchi T, Yasui H, Yamamoto N, Tanigawara Y, Nolting A, Yoshino S. Shirao K, et al. Among authors: tanigawara y. Cancer Chemother Pharmacol. 2009 Aug;64(3):557-64. doi: 10.1007/s00280-008-0904-6. Epub 2009 Jan 24. Cancer Chemother Pharmacol. 2009. PMID: 19169687 Clinical Trial.

9

A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.

Yamamoto N, Sekine I, Nakagawa K, Takada M, Fukuoka M, Tanigawara Y, Saijo N. Yamamoto N, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2009 Jul;39(7):425-30. doi: 10.1093/jjco/hyp038. Epub 2009 Apr 24. Jpn J Clin Oncol. 2009. PMID: 19395467

10

Pharmacokinetics of S-1 and CYP2A6 genotype in Japanese patients with advanced cancer.

Hirose T, Fujita K, Nishimura K, Ishida H, Yamashita K, Sunakawa Y, Mizuno K, Miwa K, Nagashima F, Tanigawara Y, Adachi M, Sasaki Y. Hirose T, et al. Among authors: tanigawara y. Oncol Rep. 2010 Aug;24(2):529-36. doi: 10.3892/or_00000889. Oncol Rep. 2010. PMID: 20596643 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters